Related Experiment Video
Updated: Nov 1, 2025

06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
919
Assessment of the Relationship between Ulcerative Colitis and Forkhead Box P3 Polymorphisms
1Department of Gastroenterology, Çukurova University School of Medicine, Turkey.
Summary
The FOXP3 rs2232365 G allele is linked to a higher risk of ulcerative colitis (UC) and disease extent. The rs3761548 polymorphism showed no significant association with UC in this study.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with no definitive cure, significantly impacting patient quality of life.
- The FOXP3 gene regulates regulatory T (Treg) cells, crucial for immune suppression and inflammation control.
- Specific FOXP3 gene polymorphisms, rs2232365 and rs3761548, have been implicated in inflammation-related diseases like UC.
Purpose of the Study:
- To investigate the association between FOXP3 gene polymorphisms (rs2232365 and rs3761548) and the risk of developing ulcerative colitis.
- To determine if these polymorphisms influence the severity or extent of UC.
Main Methods:
- A case-control study involving 146 UC patients and 292 healthy controls.
- Genotyping of FOXP3 polymorphisms (rs2232365 A/G and rs3761548 A/C) was performed using real-time polymerase chain reaction (RT-PCR).
Main Results:
- The rs2232365 G allele was significantly associated with a 1.44-fold increased risk of UC (P=0.013).
- Individuals carrying the rs2232365 G allele had a 2.56-fold higher risk for extensive UC (P=0.001).
- No statistically significant association was found for the rs3761548 polymorphism in any analysis.
Conclusions:
- The FOXP3 rs2232365 polymorphism plays a significant role in UC risk and extent in the Caucasian population.
- This study is the first to report the association of rs2232365 and rs3761548 with UC in Caucasians.
- Further research is recommended to explore the interplay of these polymorphisms with FOXP3 expression and Treg cell counts in UC patients.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
465
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
465
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
472
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
472
Drugs for Treatment of Ulcerative Colitis in IBD
284
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
284
Inflammatory Bowel Disease II: Crohn's Disease
498
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
498

